Click here if you are having trouble viewing this message
ASHM email alert banner

Read Independent Clinical Reports from ASHM Scholarship Recipients at the 2018 Conference on Retrovirus and Opportunistic Infection (CROI 2018)

Since 2015, the ASHM Scholarship Program provides a variety of scholarships to assist ASHM members, affiliates and others in the HIV, viral hepatitis and sexual health sector to attend national and international conferences to support their continuing professional development. ASHM scholarships are awarded on the basis of objective criteria overseen by an independent Scholarship Committee. They have previously been awarded to HIV and HBV S100 prescribers (GP/primary care), sexual health physicians, hospital-based specialists managing HIV, nurses and community pharmacists – who all are required to report back to colleagues and peers in the format of REPORT BACK posts with their key learnings from conference presentations that translate basic and clinical investigation into clinical practice within the field of HIV and related viruses. Five HIV clinicians reported back from Conference on Retroviruses and Opportunistic Infections (CROI 2018) from 4-7 March in Boston, Massachusetts.

Link + read to Report Back posts here:  ashm.org.au/report-back/croi-2018/
 

So PrEP works – now what?  Posted by Clare Heal

This afternoon’s series of lectures on the future of PrEP were incredible, and I was left reflecting on the future of PrEP in Australia. PrEP works, it really does, and I was compelled by Roel Coutinho to believe that if the correct risk groups are targeted, HIV indeed could be eradicated from Australia. Continue reading…


Addressing Mental Health: A Crucial Component to Ending the HIV Epidemic  Posted by Bianca F Parsons

The mind and body are one! Overall good health must include mental health. If we do not address the mental health of HIV infected individuals, we will not achieve our goal of diagnosing 90% of all patients who are HIV infected, making sure 90% of HIV patients are having their antiretroviral medication, and 90% having viral suppression. Continue reading…


Depression impacts more than just quality of life in HIV  Posted by Adrian Castelli
  • The World Health Organisation considers depression to be the leading cause of disability globally, with anxiety rating 6th. 
  • 4.4% of the world’s population is thought to be living with depression, but estimates show that at least 50% of people living with HIV/AIDS (PLWHA) satisfy criteria for at least 1 mental or substance use disorder.. Continue reading…

Life Expectancy in the Modern ART Era  Posted by Tom Turnbull 

This presentation summarised the latest data on life expectancy and the co-morbidities that are seen in people living with HIV and considered whether life expectancy has now ‘normalised’ in comparison with that of the HIV-negative population Continue reading…


Rapid Reduction in HIV Diagnoses after Targeted PrEP Implementation in NSW, Australia  Posted by Tom Turnbull

PrEP is effective in reducing recent HIV infections on a population state-wide level. More work is required to target harder-to-reach groups as PrEP was less effective in these groups in reducing recent HIV infections. Continue reading…


The Rapid ART Program Initiative for HIV Diagnosis (RAPID) in San Francisco  Posted by Tom Turnbull

Population-wide interventions/health-service design can reduce the time it takes from HIV diagnosis to first virologic suppression and the consequent population health benefits. In the RAPID program, 30% of patients commenced treatment within 5 days (2016) compared to 6% (2013). Continue reading…


Addressing Mental health: a crucial component to Ending the HIV Epidemic  Posted by Bijay Pandey

Mental health is a critical issue to properly address to achieve the 90-90-90 targets, both in people living with HIV and those at risk of HIV infection. In Australia, GPs can do much of this work as a part of their primary care practice. Continue reading…

Co-injection: Injecting drug use and HIV acquisition  Posted by Adrian Castelli

  • The rates of HIV in IVDU decreased in the US by 34% in the last decade but then stalled in 2015.
  • Sexual behaviour was associated with new infections of HIV in the IVDU community. Continue reading…

Breast is best but it’s a viral milkshake!  Posted by Clare Heal

This afternoon we were invited to consider the implications of breastfeeding from four different perspectives. Continue reading…


The Infant Gut: A Great Defense System?  Posted by Bianca F Parsons

With over 1.5 million HIV positive women becoming pregnant annually, whether or not to breastfeed becomes an important issue. Continue reading…

At the Epicentre: Identifying where and who to target for prevention of HIV  Posted by Adrian Castelli

  • Using genotype resistance assays (GRAs) to establish hot spots of increased HIV incidence finds young Latinx MSM disproportionately high across 60 clusters.
  • Phylogenetic studies show that whilst treatment-as-prevention (TaSP) is increasing and effective amongst Swiss MSM, increasing risk-associated behaviour is associated with HIV cluster growth. Continue reading…

The New Wave of Hepatitis C—Infants, Adolescents and Resistance  Posted by Adrian Castelli

The changes in management of Hepatitis C virus (HCV) has been an interesting and rewarding time for those of us who have treated patients that ultimately achieve sustained virological response (SVR) or ‘cure’, but there are still some tricky clinical situations  Continue reading…
 

Strategies for Improving the US Care Cascade: Confronting a Fragmented Health System  Posted by Tom Turnbull

There are many structural and other barriers which may prevent patients accessing care. Re-linking individuals to the same system of care that failed to engage them in the first place is not an effective strategy. Continue reading…


Switch to Bictegravir/F/TAF from DTG and ABC/3TC  Posted by Tom Turnbull

Bictegravir in a single-tablet regimen, which can be dosed without food, will become another treatment option available to HIV prescribers. It is safe and effective to switch patients from Dolutegravir/Abacavir/3TC. Continue reading…


Pathogenesis of Tuberculosis, Vaccine Prevention and Urine-based Screening  Posted by Bijay Pandey

TB reactivation is common in people with HIV with decreasing CD4 count, or other types of immunosupression. Vaccination has the promise of preventing infection, disease and reactivation. Urine-based screening has good diagnostic yield for HIV-positive patients. Continue reading…

Clinical Research Analysis and Design Workshop  Posted by Clare Heal
Phylogenetics: the study of the evolutionary history and relationships among individuals or groups of organisms (e.g. species, or populations). Continue reading…

Female Activism Vital to Inclusive HIV Eradication Effort  Posted by Adrian Castelli
"Research without community is not good research": Dr Sharon L Hillier of the University of Pittsburgh says if we are to continue to make strides in the management of HIV and toward eradication then the research is going to have to include the communities affected by what she refers to not only as a chronic but a social disease. Continue reading…

Advances in HIV Cure  Posted by Bianca Farrugia Parsons
Obstacles to HIV cure remain stubborn, and strategies to finding a cure must be two-fold: the immune control of viral replication and the elimination of the HIV reservoir. Continue reading…

Advances in Tuberculosis (TB) Treatment and Prevention  Posted by Bijay Pandey
TB is responsible for over a quarter of AIDS-related deaths worldwide. New testing and treatments, including preventative therapies are available for people living with HIV. Continue reading…